Literature DB >> 21908328

Quantification of Equid herpesvirus 5 DNA in clinical and necropsy specimens collected from a horse with equine multinodular pulmonary fibrosis.

Maria Luisa Marenzoni1, Fabrizio Passamonti, Elvio Lepri, Marta Cercone, Stefano Capomaccio, Katia Cappelli, Michela Felicetti, Giacomo Coppola, Mauro Coletti, Etienne Thiry.   

Abstract

A 15-year-old Belgian gelding was referred for fever, depression, and respiratory distress. Lung biopsy revealed interstitial fibrosis consistent with chronic interstitial pneumonia. Equid herpesvirus 5 (EHV-5) DNA was detected by polymerase chain reaction (PCR) in bronchoalveolar lavage and biopsy specimens. A presumptive diagnosis of equine multinodular pulmonary fibrosis (EMPF) was made, and the horse was administered a systemic treatment with corticosteroids and antiviral drugs. Despite initial clinical improvement, 4 weeks later, the condition of the horse rapidly deteriorated, and the animal was euthanized. Postmortem examination confirmed the presumptive diagnosis of EMPF. The EHV-5 DNA load in different tissues was estimated using a quantitative real-time PCR. Lung had a remarkable viral load, higher than in other organs, especially within the pulmonary fibrotic nodules, and a linkage between high viral burden and the most severely affected tissues was observed. The results suggest that the quantitative real-time PCR is a useful tool to quantify the EHV-5 load in different organs and to understand the relationship between EHV-5 and EMPF. The bronchoalveolar lavage was determined to be a good clinical sample to estimate the EHV-5 load in lung.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21908328     DOI: 10.1177/1040638711407890

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  7 in total

1.  Role of equine herpesviruses as co-infecting agents in cases of abortion, placental disease and neonatal foal mortality.

Authors:  Maria Luisa Marenzoni; Annalisa Bietta; Elvio Lepri; Patrizia Casagrande Proietti; Paolo Cordioli; Elena Canelli; Valentina Stefanetti; Mauro Coletti; Peter J Timoney; Fabrizio Passamonti
Journal:  Vet Res Commun       Date:  2013-09-20       Impact factor: 2.459

Review 2.  Gammaherpesvirus infections in equids: a review.

Authors:  Maria Luisa Marenzoni; Valentina Stefanetti; Maria Luisa Danzetta; Peter Joseph Timoney
Journal:  Vet Med (Auckl)       Date:  2015-04-01

3.  The effect of maternal immunity on the equine gammaherpesvirus type 2 and 5 viral load and antibody response.

Authors:  Lilja Thorsteinsdóttir; Sigríður Jónsdóttir; Sara Björk Stefánsdóttir; Valgerður Andrésdóttir; Bettina Wagner; Eliane Marti; Sigurbjörg Torsteinsdóttir; Vilhjálmur Svansson
Journal:  PLoS One       Date:  2019-06-21       Impact factor: 3.240

4.  MicroRNA let-7f-5p regulates PI3K/AKT/COX2 signaling pathway in bacteria-induced pulmonary fibrosis via targeting of PIK3CA in forest musk deer.

Authors:  Wei Zhao; Jianguo Cheng; Yan Luo; Wenlong Fu; Lei Zhou; Xiang Wang; Yin Wang; Zexiao Yang; Xueping Yao; Meishen Ren; Zhijun Zhong; Xi Wu; Ziwei Ren; Yimeng Li
Journal:  PeerJ       Date:  2022-10-05       Impact factor: 3.061

5.  Experimental induction of pulmonary fibrosis in horses with the gammaherpesvirus equine herpesvirus 5.

Authors:  Kurt J Williams; N Edward Robinson; Ailam Lim; Christina Brandenberger; Roger Maes; Ashley Behan; Steven R Bolin
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

6.  Association of Equine Herpesvirus 5 with Mild Respiratory Disease in a Survey of EHV1, -2, -4 and -5 in 407 Australian Horses.

Authors:  Charles El-Hage; Zelalem Mekuria; Kemperly Dynon; Carol Hartley; Kristin McBride; James Gilkerson
Journal:  Animals (Basel)       Date:  2021-11-30       Impact factor: 2.752

7.  Prevalence of Nasal Shedding of Equid Gammaherpesviruses in Healthy Swiss Horses.

Authors:  Laura Scheurer; Claudia Bachofen; Isabelle Hardmeier; Julia Lechmann; Angelika Schoster
Journal:  Viruses       Date:  2021-08-25       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.